Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5029 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 367 out of 503
5029 citations found

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • IPEC-J2 cell culture conditions and bacterial adherence assays:

    …To test for the effects of endogenous LT expressed by the bacteria on adherence in isogenic porcine-origin ETEC strains that had not demonstrably shown an effect of LT on colonization [14], inocula were prepared and directly applied to the IPEC-J2 cells, as described above. To test the effect of exogenous LT on adherence on these strains, LT (List Biological Laboratories) at a concentration of 1, 10, or 100 ng/ml per well was added (pre-incubation) 1 h prior to bacterial inoculation. To test the potential of GM1 ganglioside to mitigate the effects of LT on adherence, LT at a concentration of 10 ng/ml or 100 ng/ml was incubated with the cells 1 h prior to their inoculation with bacteria, and 10 ng/ml or 100 ng/ml GM1 ganglioside (Sigma) was applied to the IPEC-J2 cells at the time of bacterial inoculation. Three independent experiments were performed for each assay.

    Test of effects of different carbohydrates on LT production and secretion:

    To test the effects of different sugars on LT secretion, CAYE media containing glucose, sucrose or fructose at 0%, 0.25%, 0.5%, 1%, or 2% were prepared. Strains were cultured in different media as described above, with aliquots taken at 0, 2, 4, and 6 h post-inoculation (PI). These samples were centrifuged (2500g, 10 min), and supernatants taken to analyze for LT concentrations by GM1-ELISA as previously described [17]. Three independent experiments were performed for each assay. 

    Author did not indicate which specific lethal factor was utilized.  List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).

Using RNA-interference to investigate the innate immune response in mouse macrophages

De Arras, L;Guthrie, BS;Alper, S;

Product: ULTRA PURE LPS from Escherichia coli O111:B4

SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer

Gasser, JA;Inuzuka, H;Lau, AW;Wei, W;Beroukhim, R;Toker, A;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Cell Culture and Transfection:

    BT-20, DLD-1, HEK293T, HCC1937, HeLa, MDA-MB-435, MDA-MB-231, NIH 3T3, and MCF7 cells were cultured in DMEM (Cellgro) supplemented with 10% fetal bovine serum (FBS; GIBCO). ZR-75-1 cells were grown in RPMI 1640 supplemented with 10% FBS. MCF10A cells were maintained in DMEM/Hams F12 medium with 5% equine serum (Cellgro), 10 mg/ml insulin, 500 ng/ml hydrocortisone (Sigma-Aldrich), 20 ng/ml epidermal growth factor (EGF) (R&D Systems), and 100 ng/ml cholera toxin (List Biological Laboratories).

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Rational design of small molecules as vaccine adjuvants

Wu, TY;Singh, M;Miller, AT;De Gregorio, E;Doro, F;D'Oro, U;Skibinski, DA;Mbow, ML;Bufali, S;Herman, AE;Cortez, A;Li, Y;Nayak, BP;Tritto, E;Filippi, CM;Otten, GR;Brito, LA;Monaci, E;Li, C;Aprea, S;Valentini, S;Calabr, S;Laera, D;Brunelli, B;Caproni, E;Ma

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

RORt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis

Martinez, NE;Sato, F;Omura, S;Kawai, E;Takahashi, S;Yoh, K;Tsunoda, I;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis

Guo, Y;Chung, SK;Siu, CW;Kwan, SC;Ho, PW;Yeung, PK;Chan, KH;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

High-throughput screening technologies for botulinum neurotoxins

Bompiani, KM;Dickerson, TJ;

Product: SNAPtide® Peptide Substrate (FITC/DABCYL) for C. botulinum Type A Neurotoxin

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Control of Toll-like receptor-mediated T cell-independent type 1 antibody responses by the inducible nuclear protein IB-.

Hanihara-Tatsuzawa, F;Miura, H;Kobayashi, S;Isagawa, T;Okuma, A;Manabe, I;MaruYama, T;

Product: LPS from Escherichia coli O111:B4

  • Reagents and Antibodies:

    LPS from Escherichia coli O111:B4 was purchased from List Biological Laboratories Inc. (Campbell, CA). …

    Analysis of in Vitro CSR:

    Splenic B cells were stimulated with LPS (20 g/ml) or anti-CD40 antibodies and the additional reagents indicated below. …

    RNA Sequence:

    Total RNA were purified from LPS-stimulated (20 g/ml) splenic B cells on day 3 by RNeasy…

    ChIP Assay:

    Splenic B cells were activated with LPS plus IL-4 for 3 days. …